These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22612701)

  • 1. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
    Cramer S; Rempe R; Galla HJ
    Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
    Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
    J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal polymeric nanoparticles and brain drug delivery.
    Khalil NM; Mainardes RM
    Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
    Kreuter J
    J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
    Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
    Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
    Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
    J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticulate devices for brain drug delivery.
    Celia C; Cosco D; Paolino D; Fresta M
    Med Res Rev; 2011 Sep; 31(5):716-56. PubMed ID: 20162690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.
    Barbu E; Molnàr E; Tsibouklis J; Górecki DC
    Expert Opin Drug Deliv; 2009 Jun; 6(6):553-65. PubMed ID: 19435406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery.
    Battaglia L; Panciani PP; Muntoni E; Capucchio MT; Biasibetti E; De Bonis P; Mioletti S; Fontanella M; Swaminathan S
    Expert Opin Drug Deliv; 2018 Apr; 15(4):369-378. PubMed ID: 29338427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.
    Badhan RK; Kaur M; Lungare S; Obuobi S
    Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate systems for drug delivery and targeting to the central nervous system.
    Craparo EF; Bondì ML; Pitarresi G; Cavallaro G
    CNS Neurosci Ther; 2011 Dec; 17(6):670-7. PubMed ID: 20950327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles as novel carrier for brain delivery: a review.
    Agarwal A; Lariya N; Saraogi G; Dubey N; Agrawal H; Agrawal GP
    Curr Pharm Des; 2009; 15(8):917-25. PubMed ID: 19275654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.